Carcinoma of Esophagus
3 clinical trials · Condition
◉ Watch Carcinoma of Esophagus
| Record | Firm | Date |
|---|---|---|
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs (NCT04985357) | Travera Inc | 2024-11-01 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer (NCT01608464) | King Faisal Specialist Hospital & Research Center | 2012-05-01 |
Track Carcinoma of Esophagus automatically
Every clearance here is in the API, with alerts when new ones post.